Market Cap : 159.2 B | Enterprise Value : 188.06 B | PE Ratio : 24.77 | PB Ratio : 4.88 |
---|
NYSE:BMY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:BMY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bristol-Myers Squibb Co's Enterprise Value is $188,062 Mil. Bristol-Myers Squibb Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2022 was $14,281 Mil. Therefore, Bristol-Myers Squibb Co's EV-to-FCF for today is 13.17.
The historical rank and industry rank for Bristol-Myers Squibb Co's EV-to-FCF or its related term are showing as below:
During the past 13 years, the highest EV-to-FCF of Bristol-Myers Squibb Co was 380.98. The lowest was 7.93. And the median was 18.53.
BMY's EV-to-FCF is ranked better thanEV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2022-08-17), Bristol-Myers Squibb Co's stock price is $74.56. Bristol-Myers Squibb Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $3.010. Therefore, Bristol-Myers Squibb Co's PE Ratio for today is 24.77.
For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Bristol-Myers Squibb Co's EV-to-FCF falls into.
Bristol-Myers Squibb Co's EV-to-FCF for today is calculated as:
EV-to-FCF | = | Enterprise Value (Today) | / | Free Cash Flow (TTM) |
= | 188062.465 | / | 14281 | |
= | 13.17 |
Bristol-Myers Squibb Co's current Enterprise Value is $188,062 Mil.
Bristol-Myers Squibb Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $14,281 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Bristol-Myers Squibb Co's PE Ratio for today is calculated as:
PE Ratio | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 74.56 | / | 3.010 | |
= | 24.77 |
Bristol-Myers Squibb Co's share price for today is $74.56.
Bristol-Myers Squibb Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.010.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Greenlees Sharon | officer: SVP & Controller | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Shanahan Karin | officer: EVP, Glob. Prod. Dev. & Supply | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Meyers Gregory Scott | officer: EVP, Chief Digital & Tech Off. | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Weese Michelle | officer: EVP, Corporate Affairs | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Hidalgo Medina Manuel | director | BRISTOL MYERS SQUIBB 430 E. 29TH STREET, 14TH FLOOR NEW YORK NY 10016 |
Rice Derica W | director | 1000 NICOLLET MALL TPS-3155 MINNEAPOLIS MN 55403 |
Price Paula A | director | ONE CVS DRIVE WOONSOCKET RI 02895 |
Mily Elizabeth | officer: EVP, Strategy & BD | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVENCE LINE ROAD PRINCETON NJ 08540 |
Metcalfe Kathryn | officer: EVP, Corporate Affairs | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Vessey Rupert | officer: Pres., Research & Early Dev. | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Elkins David V | officer: EVP, Chief Financial Officer | C/O BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Bonney Michael W | director | 65 HAYDEN AVE LEXINGTON MA 02421 |
Yale Phyllis R | director | |
Ahmed Nadim | officer: President, Hematology | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Haller Julia A | director | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
From GuruFocus
Other Sources
By Zacks 2022-03-22
By Zacks 2022-04-05
By Zacks 2022-03-16
By Zacks 2022-03-30
By Zacks 2022-03-30
By Zacks 2022-03-23
By Fool 2022-03-31
By Zacks 2022-03-28
By Zacks 2022-03-29
By Zacks 2022-03-28
By Zacks 2022-03-16
By Zacks 2022-03-21
By Zacks 2022-03-21
By Zacks 2022-03-25
By Zacks 2022-03-25